Inhibition of the MEK/ERK signaling pathway blocks a subset of B cell responses to antigen

Journal of Immunology

Volumn 166, Issue 6, 2001, Pages 3855-3864

  Richards, J D ^a   Dave S H ^a   Chou, C H G ^a   Mamchak, A A ^a   DeFranco, A L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANTIGEN; B LYMPHOCYTE RECEPTOR; CD69 ANTIGEN; HERMES ANTIGEN; INTERLEUKIN 4; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; TRANSCRIPTION FACTOR EGR 1;

ANIMAL CELL; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CROSS LINKING; ENZYME INHIBITION; HUMORAL IMMUNITY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPLEEN CELL;

EID: 0035869267     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.6.3855     Document Type: Article

References (75)

1. The complexity of signaling pathways activated by the BCR
2. Reconstitution of B cell antigen receptor-induced signaling events in a nonlymphoid cell line by expressing the Syk protein-tyrosine kinase
3. B lymphocyte activation
4. Phosphatidylinositol-3-kinase activity is required for the anti-Ig-mediated growth inhibition of a human B-lymphoma cell line
5. Xid-like immunodeficiency in mice with disruption of the p85α subunit of phosphoinositide 3-kinase
6. Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85α
7. Role of phosphoinositide-derived second messengers in mediating anti-IgM-induced growth arrest of WEHI-231 B lymphoma cells
8. 1 phase restriction point
9. Mutational analysis of antigen receptor regulation of B lymphocyte growth: Evidence for involvement of the phosphoinositide signaling pathway
10. Requirement of phospholipase C-γ2 activation in surface immunoglobulin M-induced B cell apoptosis
11. 1 transition of resting B lymphocytes
12. Stimulation of murine B cells by the combination of calcium ionophore plus phorbol ester
13. Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav
14. Defective signaling through the T- and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene
15. Antigen-receptor induced clonal expansion and deletion of lymphocytes are impaired in mice lacking HS1 protein, a substrate of the antigen-receptor-coupled tyrosine kinases
16. Restoration of surface IgM-mediated apoptosis in an anti-IgM-resistant variant of WEHI-231 lymphoma cells by HS1, a protein-tyrosine kinase substrate
17. Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation
18. Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation
19. Activation of MAP kinase is necessary and sufficient for PCI2 differentiation and for transformation of NIH 3T3 cells
20. Conditionally oncogenic forms of the A-Raf and B-Raf protein kinases display different biological and biochemical properties in NIH 3T3 cells
21. High-intensity Raf signal causes cell cycle arrest mediated by p21 Cip1
22. Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21 Cip1
23. Differential activation of the ERK, JNK, and p38 mitogen-activated protein kinases by CD40 and the B cell antigen receptor
24. Extracellular signal-regulated kinase-2, but not c-Jun NH2-terminal kinase, activation correlates with surface IgM-mediated apoptosis in the WEHI 231 B cell line
25. A synthetic inhibitor of the mitogen-activated protein kinase cascade
26. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo
27. Identification of a novel inhibitor of mitogen-activated protein kinase kinase
28. Activation of c-Jun N-terminal kinase in bacterial lipopolysaccharide-stimulated macrophages
29. hi splenic B cells are an immune developmental intermediate in the production of long-lived marrow-derived B cells
30. Characterization of the B lymphocyte populations in Lyn-deficient mice and the role of Lyn in signal initiation and downregulation
31. Activation of Raf-1 and mitogen-activated protein kinase in murine macrophages partially mimics lipopolysaccharide-induced signaling events
32. Selective activation of p42 MAP kinase in murine B lymphoma cell lines by membrane immunoglobulin crosslinking: Evidence for protein kinase C-independent and -dependent mechanisms of activation
33. Differential coupling of membrane Ig and CD40 to the extracellularly regulated kinase signaling pathway
34. Regulation of transcription by MAP kinase cascades
35. Mitogen-activated protein kinase kinase inhibition does not block the stimulation of glucose utilization by insulin
36. Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor
37. MAP kinase kinase kinase. MAP kinase kinase, and MAP kinase
38. Induction of early response genes by cross-linking membrane Ig on B lymphocytes
39. ras pathway couples antigen receptor stimulation to induction of the primary response gene egr-1 in B lymphocytes
40. A role for EGR 1 in regulation of stimulus-dependent CD44 transcription in B lymphocytes
41. Transcriptional regulation of the Icam-1 gene in antigen receptor and phorbol ester stimulated B lymphocytes: Role for transcription factor EGR1
42. Transcriptonal regulation of the gene encoding the human C-type lectin leukocyte receptor AIM/CD69 and functional characterization of its tumor necrosis factor-α-responsive elements
43. The role of B7 costimulation in T-cell immunity
44. Anti-immunoglobulins induce death by apoptosis in WEHI-231 B lymphoma cells
45. Anti-immunoglobulin antibodies induce apoptosis in immature B cell lymphomas
46. Negative selection of immature B cells by receptor editing or deletion is determined by site of antigen encounter
47. B-cell stimulatory factor I activates resting B cells
48. B-cell growth factor (B-cell growth factor I or B-cell stimulating factor, provisional I) is a differentiation factor for resting B cells and may not induce cell growth
49. Interleukin-4 enhances anti-IgM stimulation of B cells by improving cell viability and by increasing the sensitivity of B cells to the anti-IgM signal
50. Inhibition of mitogen-activated protein kinase kinase blocks T cell proliferation but does not induce or prevent anergy
51. MEK inhibitors: The chemistry and biological activity of U0126, its analogs, and cyclization products
52. A ternary complex factor-dependent mechanism mediates induction of egr-1 through selective serum response elements following antigen receptor crosslinking in B lymphocytes
53. Induction of cell cycle regulatory proteins in anti-immunoglobulin-stimulated mature B lymphocytes
54. Regulation of the catalytic subunit (p34PKS-J3/cdk4) for the major D-type cyclin in mature B lymphocytes
55. 1 cell cycle stage following delivery of complete versus partial activation stimuli
56. Transcription factors of the NFAT family: Regulation and function
57. IRS-1: Essential for insulin- and IL-4-stimulated mitogenesis in hematopoietic cells
58. Common elements in interleukin 4 and insulin signaling pathways in factor-dependent hematopoietic cells
59. Essential role of Stat6 in IL-4 signalling
60. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene
61. Stat6 is required for mediating responses to IL-4 and for the development of Th2 cells
62. Role of lymphocyte adhesion receptors in transient interactions and cell locomotions
63. ras activation in T cell CD69 expression
64. Raf-1 provides a dominant but not exclusive signal for the induction of CD69 expression in T cells
65. How self-tolerance and the immunosuppressive drug FK506 prevent B-cell mitogenesis
66. The cooperative interaction of two different signaling pathways in response to bufalin induces apoptosis in human leukemia U937 cells
67. Mitogen-activated protein kinase-mediated Fas apoptotic signaling pathway
68. The mitogen-activated protein kinase phosphatases PAC1, MKP-1, and MKP-2 have unique substrate specificities and reduced activity in vivo toward the ERK2 sevenmaker mutation
69. Conditional expression of the mitogen-activated protein kinase (MAPK) phosphatase MKP-1 preferentially inhibits p38 MAPK and stress-activated protein kinase in U937 cells
70. Conditional expression of mitogen-activated protein phosphatase-1 MKP-1 is cytoprotective against UV-induced apoptosis
71. Cyclic strain stress-induced mitogen-activated protein kinase (MAPK) phosphatase 1 expression in vascular smooth muscle cells is regulated by Ras/Rac-MAPK pathways
72. CD40 ligation results in protein kinase C-independent activation of ERK and JNK in resting murine splenic B cells
73. A comparison of signaling requirements for apoptosis of human B lymphocytes induced by the B cell receptor and CD95/Fas
74. Involvement of stress-activated protein kinase and p38 mitogen-activated protein kinase in mIgM-induced apoptosis of human B lymphocytes
75. The p38 mitogen-activated protein kinase is activated by ligation of the T or B lymphocyte antigen receptors. Fas or CD40, but suppression of kinase activity does not inhibit apoptosis induced by antigen receptors